Clinical officer

Revere Partners Appoints Renowned Dental and Financial Experts to Help Reach Fund Goal of $200M AUM

Retrieved on: 
Thursday, October 13, 2022
Technology, Finance, Banking, Dental, Professional Services, Socially Responsible Investing, Health, General Health, Consumer Electronics, Trident, Dentist, LinkedIn, Time, American Dental Education Association, Rural Health Workforce and The Patient Protection and Affordable Care Act, Delta Dental, Consultant, ADSO, MS, Growth, ADA, Partner, IRR, LLC, Associate, General counsel, Dental, Align Technology, Entrepreneurship, Private practice, Assets under management, Facebook, AUM, Technology, Organization, American Journal of Orthodontics and Dentofacial Orthopedics, American Dental Association, DMD, Marketing, Doctor of Philosophy, Industry, Dentistry, Arena, Orthodontics, Association, CEO, Social media, Innovation, Dental care, Telehealth, Clinical officer, Silicon, Krell, Database, DSOS, 2010 Missouri State Auditor election, Renewable energy, Private investigator, Management, Health insurance, Walmart

Revere Partners identifies opportunities for investors and provides capital for cutting-edge innovations in the oral health and systemic health sectors.

Key Points: 
  • Revere Partners identifies opportunities for investors and provides capital for cutting-edge innovations in the oral health and systemic health sectors.
  • Revere Partners is well-positioned to take advantage of the growing dental industry, which is projected to surpass $230 billion in total revenues by 2023.
  • Early-stage dental startups are poised for strong growth in the coming years, and Dr. Krell and Revere Partners are opening doors to lead that expansion.
  • Revere Partners has also tapped an influential team of Associates that span the entire dental industry.

Asensus Surgical Announces the Appointment of Two New Board Members

Retrieved on: 
Monday, July 26, 2021
Technology, Surgery, Medical devices, FDA, Other Health, Health, Pharmaceutical, General Health, Data management, Medicine, Clinical medicine, Health care, Digestive system surgery, Endoscopy, Laparoscopy, Preventive healthcare, Clinical officer, Surgery, Surgical specialties

She currently serves as the Deputy Chief Clinical Officer at Anthem, Inc., a position she has held since December 2020.

Key Points: 
  • She currently serves as the Deputy Chief Clinical Officer at Anthem, Inc., a position she has held since December 2020.
  • She completed her residency in Preventive Care at Harvard Preventive Care and is Board Certified in Preventive Care and Occupational Medicine.
  • I am thrilled to join the Asensus Surgical Board of Directors at such an important time for the company, said Mr. Hobert.
  • This builds upon the foundation of Digital Laparoscopy with the Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability.

Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory Board

Retrieved on: 
Thursday, June 24, 2021
Biotechnology, Alternative medicine, FDA, Health, General Health, Pharmaceutical, Mental health, Other Science, Research, Science, Clinical trials, Food and Drug Administration, United States Public Health Service, Clinical officer, Health

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (Cybin or the Company), a biotechnology company focused on progressing psychedelic therapeutics, today announced the addition of Dr. Thomas Laughren, to the Clinical Advisory Board.

Key Points: 
  • Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (Cybin or the Company), a biotechnology company focused on progressing psychedelic therapeutics, today announced the addition of Dr. Thomas Laughren, to the Clinical Advisory Board.
  • Dr. Thomas Laughren formerly served as the Director for the Division of Psychiatry Products, Center for Drug Evaluation and Research at the FDA where he served for 29 years.
  • The Board will be chaired by Alex Belser, PhD, Cybins Chief Clinical Officer.
  • We are excited to welcome Dr. Laughren to Cybins Clinical Advisory Board to provide guidance as we develop our regulatory strategies.

Trinity Health Names Mark LePage, M.D., as Senior Vice President of Medical Groups and Ambulatory Strategy

Retrieved on: 
Wednesday, June 23, 2021
Trinity Health, Clinical officer

LIVONIA, Mich., June 23, 2021 /PRNewswire/ --Trinity Health today announced it has named Mark LePage, M.D., M.B.A., as the new senior vice president, medical groups and ambulatory strategy, effective July 1, 2021.

Key Points: 
  • LIVONIA, Mich., June 23, 2021 /PRNewswire/ --Trinity Health today announced it has named Mark LePage, M.D., M.B.A., as the new senior vice president, medical groups and ambulatory strategy, effective July 1, 2021.
  • In this position, LePage will take on national responsibility for Trinity Health's medical groups, leading more than 6,800 physicians and clinicians.
  • LePage comes to the position after spending four years as the first physician CEO of IHA, Trinity Health's largest multi-specialty medical group.
  • "We look forward to the leadership Mark will bring as Trinity Health continues to advance our medical groups and ambulatory strategy to deliver an exceptional member experience and excellent clinical, operational, and financial outcomes," said Trinity Health chief clinical officer Dan Roth, M.D.

Howard Shaps, MD, MBA, Named Chief Clinical Officer at Healthmap Solutions

Retrieved on: 
Tuesday, June 15, 2021
Epidemiology, Centene Corporation, Clinical officer, HealthMap, Health

TAMPA, Fla., June 15, 2021 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), an industry leading NCQA accredited kidney population health management company, today announced the appointment of Dr. Howard Shaps, MD, MBA, as its Chief Clinical Officer.

Key Points: 
  • TAMPA, Fla., June 15, 2021 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), an industry leading NCQA accredited kidney population health management company, today announced the appointment of Dr. Howard Shaps, MD, MBA, as its Chief Clinical Officer.
  • Dr. Shaps is a member of the Healthmap Executive Leadership Team and reports directly to Eric Reimer, Chief Executive Officer and Co-chairman of the Board of Directors.
  • Most recently, he was Deputy Chief Medical Officer at Centene Corporation, where he had direct oversight of medical management and supported the policy, vendor management, and clinical strategy teams.
  • Today, Healthmap Solutions uses that experience to power a complex KHM program with its clinical experts.

Prospero Health Appoints Dr. Kris Smith as Chief Clinical Officer and Dr. Theresa Soriano as Associate Chief Clinical Officer

Retrieved on: 
Wednesday, May 5, 2021
Nursing, Mental health, Health, Consumer, Seniors, Other Health, Managed care, Health care, Northwell Health, Town of North Hempstead, New York, Clinical officer, Mount Sinai Health System, Health

b'Prospero Health, a physician-led home-based medical care provider that supports over 12,000 people facing serious illness, recently announced the hiring of two nationally recognized home-based medical care leaders: Dr. Kris Smith serves as Chief Clinical Officer and Dr. Theresa Soriano serves as Associate Chief Clinical Officer.

Key Points: 
  • b'Prospero Health, a physician-led home-based medical care provider that supports over 12,000 people facing serious illness, recently announced the hiring of two nationally recognized home-based medical care leaders: Dr. Kris Smith serves as Chief Clinical Officer and Dr. Theresa Soriano serves as Associate Chief Clinical Officer.
  • Smith and Dr. Soriano understand that health care has typically been organized around the customs of the health care system, as opposed to the needs of patients and families,\xe2\x80\x9d said Doug Wenners, co-Founder and Chief Executive Officer of Prospero.
  • Prior to naviHealth, Dr. Smith was the Senior Vice President of Population Health at Northwell Health, where he provided population health strategic leadership and oversaw all care management activities.
  • Before joining Northwell, Dr. Smith was a clinical researcher, assistant program director, and clinician at the Mount Sinai Health system.

Pennsylvania College of Health Sciences to Launch New Medical Assistant Program

Retrieved on: 
Tuesday, March 30, 2021
Health care, Health, Pennsylvania College of Health Sciences, Medical assistant, College of Health Sciences, Clinical officer, University of Kentucky College of Health Sciences

Pennsylvania College of Health Sciences' nine-month full-time Medical Assistant Program will allow students to learn the specialized skills to play a key support role as an administrator or clinician in a medical office.

Key Points: 
  • Pennsylvania College of Health Sciences' nine-month full-time Medical Assistant Program will allow students to learn the specialized skills to play a key support role as an administrator or clinician in a medical office.
  • "Medical assistants are a critical part of a health care team, providing administrative and clinical support services to ensure care delivery is efficient and effective," said Heather Myers, Program Director for the Medical Assistant Program at Pennsylvania College of Health Sciences.
  • "PA College is dedicated to continually developing new programs to reflect the needs of the health care community in our area," said Dr. Karen Dielmann, Dean of Health Sciences for Pennsylvania College of Health Sciences.
  • To learn more about the new Medical Assistant Program, visit: https://www.pacollege.edu/academics/health-sciences-certificate-programs...
    To learn more about Pennsylvania College of Health Sciences, please visit: http://www.PAcollege.edu .

Cybin Announces Senior Management Changes to Lead Buildout of Development and Clinical Capabilities in the United States and Europe

Retrieved on: 
Tuesday, March 30, 2021
Biotechnology, Mental health, Health, Pharmaceutical, Clinical trials, Clinical officer, OTC Markets Group, Health care, Health, Contract research organizations

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (Cybin or the Company), a biotechnology company focused on progressing psychedelic therapeutics, today announced key senior management changes to lead the buildout of its development and clinical operations in the United States and Europe.

Key Points: 
  • Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (Cybin or the Company), a biotechnology company focused on progressing psychedelic therapeutics, today announced key senior management changes to lead the buildout of its development and clinical operations in the United States and Europe.
  • Effective immediately, Alexander Belser, PhD, will serve as Chief Clinical Officer, and Aaron Bartlone will serve as Chief Operating Officer of Cybin US Holdings Inc.
  • These appointments will serve to strengthen our development and clinical operations globally and solidify Cybins position within the industry.
  • Alex and Aaron bring deep clinical, commercial and regulatory expertise that will serve to broaden our management and scientific leadership teams.

Brown & Toland Physicians Welcomes K. Warren Volker, MD, PhD, as Chief Medical Officer

Retrieved on: 
Tuesday, February 23, 2021
Intermountain Healthcare, Toland, Clinical officer

OAKLAND, Calif., Feb. 23, 2021 /PRNewswire/ -- Brown & Toland Physicians announced today the selection of K. Warren Volker, MD, PhD, as chief medical officer.

Key Points: 
  • OAKLAND, Calif., Feb. 23, 2021 /PRNewswire/ -- Brown & Toland Physicians announced today the selection of K. Warren Volker, MD, PhD, as chief medical officer.
  • He joins Brown & Toland from Intermountain Healthcare, a Nevada multispecialty medical group where he was chief clinical officer.
  • Volker assumes the chief medical officer role from Brown & Toland president, Joel Klompus, MD, who has been serving in the interim.
  • Brown & Toland Physicians is a leading network of independent doctors focused on delivering personalized and high-quality health care to the San Francisco Bay Area.

Lisa Newell Joins Corridor as Chief Clinical Officer

Retrieved on: 
Wednesday, January 27, 2021
Clinical officer

OVERLAND PARK, Kan., Jan. 27, 2021 /PRNewswire/ --The Corridor Group Holdings, LLC ("Corridor") is pleased to announce that Lisa Newell has joined its leadership team as Chief Clinical Officer.

Key Points: 
  • OVERLAND PARK, Kan., Jan. 27, 2021 /PRNewswire/ --The Corridor Group Holdings, LLC ("Corridor") is pleased to announce that Lisa Newell has joined its leadership team as Chief Clinical Officer.
  • At Corridor, Ms. Newell will be responsible for quality and clinical leadership, organizing and engaging Corridor's clinical, operational and analytical resources to achieve client success.
  • Corridor CEO Des Varady said, "Lisa is an exceptional leader with a strong track record of strategic, clinical and analytical accomplishments in post-acute healthcare.
  • We are excited to have her join our team as Chief Clinical Officer and know that her experience will be invaluable to our clients."